Vaccine News and Research

Latest Vaccine News and Research

Findings may help develop new antiviral drugs for influenza

Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.

22 Dec 2009

One dose of vaccine may be effective to protect infants and children from H1N1 virus, shows study

One dose of vaccine may be effective to protect infants and children and reduce transmission of the H1N1 virus, according to a study in JAMA, published online today because of its public health implications. The study will appear in the January 6 print edition of the journal.

21 Dec 2009

Positive interim results from Idera Pharmaceuticals' IMO-2125 Phase 1 clinical trial for HCV

Idera Pharmaceuticals, Inc. today announced positive interim results from a Phase 1 clinical trial of IMO-2125 in patients with chronic hepatitis C virus infection (HCV). IMO-2125 is an agonist of Toll-like Receptor 9 that Idera designed to treat HCV by inducing endogenous interferon-alpha and other Th1-type cytokines and chemokines.

21 Dec 2009

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.

21 Dec 2009

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.

21 Dec 2009

More than 40 groups join together to oppose Senate healthcare bill, hold online Virtual Vigil

More than 40 groups have joined together to oppose the Senate healthcare bill, and will hold an online "Virtual Vigil" starting at 9 pm tonight and wrapping after the Senate votes around 1 am.

21 Dec 2009

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

An experiemental nasally administered malaria vaccine prevented parasite transmission from infected mice to mosquitoes and could play an important role in the fight against human malaria. The researchers from Japan report their findings in the December 2009 issue of the journal Infection and Immunity.

19 Dec 2009

Second wave of H1N1 virus infection in the U.S. comes to an end

Rates of 2009 H1N1 influenza virus testing in the U.S. have declined more than 75 percent since their peak in late October, suggesting that the "second wave" of virus infection that sickened tens of millions of Americans since it began four months ago may be coming to an end, according to a new report by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services.

19 Dec 2009

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Despite a 100-fold increase in H1N1 influenza cases in the Seattle area during spring 2009, an aggressive infection control program to protect immunocompromised cancer patients and thorough screening measures resulted in no corresponding increase in H1N1 cases among the total patient population at the Seattle Cancer Care Alliance, according to a new study by researchers and physicians at Fred Hutchinson Cancer Research Center and the SCCA.

19 Dec 2009

Akorn exits vaccine distribution business

Akorn, Inc. today announced that it failed to reach an amicable resolution to a longer term and strategic business arrangement with the supplier of its Tetanus Diphtheria (“Td”) vaccine and as a result will be exiting the business. The existing supply agreement will end on March 14, 2010. The company previously announced its intent to exit the distribution of flu vaccines.

19 Dec 2009

MinuteClinic medical clinics in select CVS/pharmacy stores offer H1N1 vaccinations

MinuteClinic medical clinics in select CVS/pharmacy stores throughout Maryland, North Carolina and Tennessee are now offering H1N1 vaccinations on demand seven days a week with no appointment necessary.

19 Dec 2009

Sanofi Pasteur pediatric H1N1 vaccine recall: No danger and no need of an extra dose

There is no danger if your child received the H1N1 vaccine that was recalled by Sanofi Pasteur. That is the information being provided to anyone calling the NJ Poison Control Center's hotline, according to Bruce Ruck, Pharm.D., Director of Drug Information and Professional Education. The public should be reassured that this recall took place because specific lots were found to be slightly weaker than they should have been.

19 Dec 2009

Recent releases in Global Health

A Scientific American article examines recent efforts to tackle neglected tropical diseases (NTDs). The author writes "NTDs have plagued humankind for thousands of years. … What is new, however, is that donors, drugmakers, health ministries in low- and middle-income countries, the World Health Organization (WHO), and public-private partnerships are linking their efforts to combat the NTDs in a more coordinated and systematic way."

18 Dec 2009

Opinion: Uganda anti-gay bill; Shah confirmation

Columnist Michael Gerson in a Washington Post opinion piece writes of Uganda's Anti-Homosexuality Bill of 2009 being considered by the country's parliament "that would impose new and harsher penalties on homosexuality, including life imprisonment and capital punishment. It also would force pastors and others to report homosexuals to the authorities.

18 Dec 2009

National Journal examines USAID administrator nominee's experience, prospects at the Agency

The National Journal looks at the professional background of Rajiv Shah, President Barack Obama's nominee to be the USAID administrator. "As Rajiv Shah prepares to lead the U.S. Agency for International Development, former colleagues, lobbyists and current and past administration officials paint a picture of a man with dizzying brainpower and social intelligence who has won over skeptics time and again.

18 Dec 2009

H1N1 cases still increasing in many countries; WHO to begin shipping donated vaccines within weeks

With many countries continuing to report a growing number of H1N1 (swine flu) cases, Keiji Fukuda, special adviser to the WHO director general on pandemic influenza, said Thursday it was too early to declare the pandemic over, the Washington Post reports.

18 Dec 2009

EMA's CHMP issues positive opinion for Cangene's Human Hepatitis B Immunoglobulin product

Cangene Corporation today reports that it has received a positive opinion from the EMA's Committee for Medicinal Products for Human Use ("CHMP") regarding the immunoprophylaxis indication of Cangene's ImmunoGam(TM) (Human Hepatitis B Immunoglobulin).

18 Dec 2009

Human protein may help prevent H1N1 infection

Howard Hughes Medical Institute researchers have identified a naturally occurring human protein that helps prevent infection by H1N1 influenza and other viruses, including West Nile and dengue virus.

18 Dec 2009

Liquidia Technologies to receive $3 million in funding from NIST

Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department’s National Institute of Standards and Technology (NIST) to further develop and scale-up the company’s PRINT manufacturing process.

18 Dec 2009

BDI Pharma introduces SecuriVAX for online ordering of vaccines

BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced today the introduction of SecuriVAX(SM) (www.securivax.com), an online supply solution providing the healthcare community a one-stop source for a wide variety of vaccines.

18 Dec 2009

Vaccine News and Research

Latest Vaccine News and Research

Findings may help develop new antiviral drugs for influenza

One dose of vaccine may be effective to protect infants and children from H1N1 virus, shows study

Positive interim results from Idera Pharmaceuticals' IMO-2125 Phase 1 clinical trial for HCV

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

More than 40 groups join together to oppose Senate healthcare bill, hold online Virtual Vigil

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

Second wave of H1N1 virus infection in the U.S. comes to an end

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Akorn exits vaccine distribution business

MinuteClinic medical clinics in select CVS/pharmacy stores offer H1N1 vaccinations

Sanofi Pasteur pediatric H1N1 vaccine recall: No danger and no need of an extra dose

Recent releases in Global Health

Opinion: Uganda anti-gay bill; Shah confirmation

National Journal examines USAID administrator nominee's experience, prospects at the Agency

H1N1 cases still increasing in many countries; WHO to begin shipping donated vaccines within weeks

EMA's CHMP issues positive opinion for Cangene's Human Hepatitis B Immunoglobulin product

Human protein may help prevent H1N1 infection

Liquidia Technologies to receive $3 million in funding from NIST

BDI Pharma introduces SecuriVAX for online ordering of vaccines

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Vaccine News and Research

Latest Vaccine News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in